INTANGIBLE ASSETS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
Total	$ 2,363,854		$ 2,363,854		$ 2,720,541
Amortization expense	201,718	$ 119,763	599,880	$ 355,385
Future aggregate amortization expense for intangible assets [Abstract]
Total	2,363,854		2,363,854		2,720,541
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	9,625,938		9,625,938		9,625,938
Less: accumulated amortization	(7,262,084)		(7,262,084)		(6,905,397)
Total	2,363,854		2,363,854		2,720,541
Amortization expense	119,763	$ 119,763	356,687	$ 355,385
Future aggregate amortization expense for intangible assets [Abstract]
2016 (Three months)	119,763		119,763
2017	475,148		475,148
2018	475,148		475,148
2019	475,148		475,148
2020	476,450		476,450
2021 & Beyond	342,197		342,197
Total	2,363,854		2,363,854		2,720,541
Patents [Member] | Amlexanox (Aphthasol) [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	2,090,000		2,090,000		2,090,000
Patents [Member] | Amlexanox (OraDiscA) [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	6,873,080		6,873,080		6,873,080
Patents [Member] | OraDisc [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	73,000		73,000		73,000
Patents [Member] | Hydrogel Nanoparticle Aggregate [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 589,858		$ 589,858		$ 589,858